<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[GlaxoSmithKline Plc. | Company News & Executive Profiles - GSK | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/glaxosmithkline+plc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for GlaxoSmithKline Plc.]]></description>
	<s:counts start="0" returned="10" found="916" />
	<language>en-us</language>
	<item>
		<title><![CDATA[FTSE Down 0.5 Pct on Caution]]></title>
		<link><![CDATA[http://www.bnet.com/2407-13071_23-370363.html]]></link>
		<description><![CDATA[By Simon FalushLONDON (<a href="http://resources.bnet.com/index.php?source=ReutersUK">Reuters UK</a>) - Caution ahead of a key jobs report from the United States weighed on banks and other cyclical stocks, pushing the FTSE 100  share index 0.5 percent lower by midsession on Friday.By 12:16 p.m. the FTSE 100 was down 28.59 points at 5,284.41, tracking...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_reutersUK.gif" type="image/gif" />
		<pubDate>Fri, 04 Dec 2009 05:04:25 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/bank.html"><![CDATA[Bank]]></category>
		<category domain="http://resources.bnet.com/topic/investor.html"><![CDATA[Investor]]></category>
		<category domain="http://resources.bnet.com/topic/ftse.html"><![CDATA[FTSE]]></category>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/blount+international+inc..html"><![CDATA[Blount International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/bmb+munai+inc..html"><![CDATA[BMB Munai Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/kraft+foods+inc..html"><![CDATA[Kraft Foods Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/standard+parking+corp..html"><![CDATA[Standard Parking Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/us.html"><![CDATA[US]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BLT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">KAZ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">KFT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">STAN</category>
		<category domain="tickers">AZN,BLT,KAZ,GSK,KFT,STAN</category>
	</item>
	<item>
		<title><![CDATA[GSK expands Aspen deal; Pfizer talks with Cipla]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/news-analysis/gsk-expands-aspen-pfizer-talks/22286/]]></link>
		<description><![CDATA[Generics are hot commodities these days--and the following two stories illustrate this fact. First, GlaxoSmithKline has finalized its buyout of a stake in South Africa's Aspen Pharmacare Holdings. Aiming to diversify into selling copycats of its own meds, Glaxo decided to take an even larger stake of Aspen than it...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Tue, 01 Dec 2009 09:25:12 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/thomson+reuters+corp..html"><![CDATA[Thomson Reuters Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/ranbaxy+laboratories+ltd..html"><![CDATA[Ranbaxy Laboratories Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/aspen+technology+inc..html"><![CDATA[Aspen Technology Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZPN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RBXZ F</category>
		<category domain="tickers">AZPN,GSK,PFE,RBXZ F</category>
	</item>
	<item>
		<title><![CDATA[GlaxoSmithKline Target of Claims That Denture Cream Causes Neurological Problems]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005523/glaxosmithkline-target-of-claims-that-denture-cream-causes-neurological-problems/]]></link>
		<description><![CDATA[Could denture cream become GlaxoSmithKline GSK's new Paxil -- a blockbuster product that becomes the target of mass litigation? Lawyers have brought at least a dozen cases and are potentially preparing as many as 3,000 against GSK and Procter & Gamble PG over the use of zinc in the denture...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Fri, 27 Nov 2009 18:34:54 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/litigation.html"><![CDATA[Litigation]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="tickers">GSK</category>
	</item>
	<item>
		<title><![CDATA[FTSE Falls, Dubai Jitters Weigh]]></title>
		<link><![CDATA[http://www.bnet.com/2407-13071_23-368470.html]]></link>
		<description><![CDATA[By Simon FalushLONDON (<a href="http://resources.bnet.com/index.php?source=ReutersUK">Reuters UK</a>) - The top share index fell for a second session on Friday, as banks were pressured by persisting anxiety over Dubai's debt standstill while miners and energy stocks were weighed by falling commodity prices.By 9:26 a.m. the FTSE 100  was down 0.3 percent or...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_reutersUK.gif" type="image/gif" />
		<pubDate>Fri, 27 Nov 2009 02:00:21 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/bank.html"><![CDATA[Bank]]></category>
		<category domain="http://resources.bnet.com/topic/dubai.html"><![CDATA[Dubai]]></category>
		<category domain="http://resources.bnet.com/topic/investor.html"><![CDATA[Investor]]></category>
		<category domain="http://resources.bnet.com/topic/ftse.html"><![CDATA[FTSE]]></category>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/royal+dutch+shell+plc..html"><![CDATA[Royal Dutch Shell Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/standard+parking+corp..html"><![CDATA[Standard Parking Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RDSA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">STAN</category>
		<category domain="tickers">AZN,GSK,RDSA,STAN</category>
	</item>
	<item>
		<title><![CDATA[GlaxoSmithKline Seeks to Commercialize Viread in China for Hepatitis B]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F175261-glaxosmithkline-seeks-to-commercialize-viread-in-china-for-hepatitis-b%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[ChinaBio Today submits:  GlaxoSmithKline GSK and Gilead Sciences GILD agreed on an Asian marketing plan for their jointly owned treatment for hepatitis B, Viread® tenofovir disoproxil fumarate. GSK will have exclusive rights to commercialize the drug for hepatitis B in China. Gilead will own exclusive rights Hong Kong, Singapore,...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 25 Nov 2009 04:11:15 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/chinabio+today.html"><![CDATA[ChinaBio Today]]></category>
		<category domain="http://resources.bnet.com/topic/gilead+sciences+inc..html"><![CDATA[Gilead Sciences Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GILD</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="tickers">GILD,GSK</category>
	</item>
	<item>
		<title><![CDATA[GlaxoSmithKline Takes 'Three-Pronged' Approach in China to Fight H1N1 Flu]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F174695-glaxosmithkline-takes-three-pronged-approach-in-china-to-fight-h1n1-flu%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[ChinaBio Today submits:  GlaxoSmithKline (NYSE: GSK) will begin manufacturing its treatment for flu, Relenza, in China to supply China&#8217;s domestic market. GSK received approval of the drug in September from the SFDA. Relenza, like Tamiflu from Roche (RHHBY.PK), aims at reducing both the severity and the duration of flu...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Sun, 22 Nov 2009 04:50:01 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/chinabio+today.html"><![CDATA[ChinaBio Today]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="tickers">GSK</category>
	</item>
	<item>
		<title><![CDATA[FTSE Ends Lower For 4th Day]]></title>
		<link><![CDATA[http://www.bnet.com/2407-13071_23-366962.html]]></link>
		<description><![CDATA[By Tricia WrightLONDON (<a href="http://resources.bnet.com/index.php?source=ReutersUK">Reuters UK</a>) - The top share index ended in negative territory for a fourth consecutive session on Friday as weakness in commodity stocks and banks outweighed gains from defensive pharmaceuticals.The FTSE 100  ended down 16.29 points, or 0.3 percent, at 5,251.41 points, the lowest close since...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_reutersUK.gif" type="image/gif" />
		<pubDate>Fri, 20 Nov 2009 10:00:56 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/bp+plc.html"><![CDATA[BP Plc]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[Stock]]></category>
		<category domain="http://resources.bnet.com/topic/investor.html"><![CDATA[Investor]]></category>
		<category domain="http://resources.bnet.com/topic/ftse.html"><![CDATA[FTSE]]></category>
		<category domain="http://resources.bnet.com/topic/bhp+billiton.html"><![CDATA[BHP Billiton]]></category>
		<category domain="http://resources.bnet.com/topic/blount+international+inc..html"><![CDATA[Blount International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/bmb+munai+inc..html"><![CDATA[BMB Munai Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/curtiss-wright+corp..html"><![CDATA[Curtiss-Wright Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/royal+dutch+shell+plc..html"><![CDATA[Royal Dutch Shell Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/standard+parking+corp..html"><![CDATA[Standard Parking Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/tractor+supply+co..html"><![CDATA[Tractor Supply Co.]]></category>
		<category domain="http://resources.bnet.com/topic/trane.html"><![CDATA[Trane]]></category>
		<category domain="http://resources.bnet.com/topic/vodafone+group+plc..html"><![CDATA[Vodafone Group Plc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BLT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">KAZ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CW</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RDSA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">STAN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">TSCO</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">TT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VOD</category>
		<category domain="tickers">BLT,KAZ,CW,GSK,RDSA,STAN,TSCO,TT,VOD</category>
	</item>
	<item>
		<title><![CDATA[Glaxo Receives Approval for Its H1N1 Vaccine]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F173578-glaxo-receives-approval-for-its-h1n1-vaccine%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Zacks.com submits:   GlaxoSmithKline plc GSK recently received approval from the U.S. Food and Drug Administration FDA for its unadjuvanted influenza A (H1N1) pandemic vaccine.  The FDA approved the supplemental biologics license application sBLA, which was filed as a strain change supplement to Glaxo&#8217;s FluLaval seasonal flu vaccine....]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 16 Nov 2009 08:40:48 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/zacks.com.html"><![CDATA[Zacks.com]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="tickers">GSK</category>
	</item>
	<item>
		<title><![CDATA[Glaxo Reports Higher Revenues in Third Quarter]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F173026-glaxo-reports-higher-revenues-in-third-quarter%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Zacks.com submits:   GlaxoSmithKline, plc GSK reported third quarter income of 92 cents per American Depository Share ADS, 3 cents below the Zacks Consensus Estimate. The company reported earnings of 94 cents in the year-ago period. Third quarter 2009 revenue increased 3%, with growth being driven by strong performances...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 12 Nov 2009 08:50:27 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/zacks.com.html"><![CDATA[Zacks.com]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="tickers">GSK</category>
	</item>
	<item>
		<title><![CDATA[GlaxoSmithKline Wins FDA Approval for Cancer Drug]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F169608-glaxosmithkline-wins-fda-approval-for-cancer-drug%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Zacks.com submits:   GlaxoSmithKline GSK and Denmark-based Genmab received some good news with the US Food and Drug Administration&#8217;s FDA approval for Arzerra ofatumumab, a monoclonal antibody for patients with chronic lymphocytic leukemia CLL, a slowly progressing cancer of the blood and bone marrow.  Arzerra is approved for...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 28 Oct 2009 01:03:56 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/zacks.com.html"><![CDATA[Zacks.com]]></category>
		<category domain="http://resources.bnet.com/topic/glaxosmithkline+plc..html"><![CDATA[GlaxoSmithKline Plc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
		<category domain="tickers">GSK</category>
	</item>
</channel>
</rss>
